* Transmedics Group Inc TMDX.OQ reported quarterly
adjusted
earnings of 12 cents per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -21 cents. The mean expectation of
six analysts for the quarter was for a loss of 3 cents per
share. Wall Street expected results to range from -8 cents to 8
cents per share.
* Revenue rose 158.7% to $81.17 million from a year ago;
analysts
expected $68.51 million.
* Transmedics Group Inc's reported EPS for the quarter was
12
cents.
* The company reported quarterly net income of $4.03
million.
* Transmedics Group Inc shares had risen by 5.3% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Transmedics
Group
Inc is $92.00
This summary was machine generated from LSEG data February 26 at
10:41 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.03 0.12 Beat
Sep. 30 2023 -0.16 -0.78 Missed
Jun. 30 2023 -0.13 -0.03 Beat
Mar. 31 2023 -0.25 -0.08 Beat